Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SB Berger
Characterization of GSK′963: A Structurally Distinct, Potent and Selective Inhibitor of RIP1 Kinase
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Related publications
CC-223, a Potent and Selective Inhibitor of mTOR Kinase: In Vitro and in Vivo Characterization
Molecular Cancer Therapeutics
Cancer Research
Oncology
Characterization of Structurally Distinct, Isoform-Selective Phosphoinositide 3'-Kinase Inhibitors in Combination With Radiation in the Treatment of Glioblastoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Discovery of a Selective Inhibitor of Oncogenic B-Raf Kinase With Potent Antimelanoma Activity
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Discovery of Zanubrutinib (BGB-3111), a Novel, Potent and Selective Covalent Inhibitor of Brutons Tyrosine Kinase
Preclinical Characterization of Anlotinib, a Highly Potent and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitor
Cancer Science
Cancer Research
Medicine
Oncology
Nonclinical and Clinical Pharmacological Characterization of the Potent and Selective Cathepsin K Inhibitor MIV-711
Journal of Translational Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
TAS0728, a Covalent-Binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Inhibition of Angiogenesis by Staurosporine, a Potent Protein Kinase Inhibitor.
Journal of Antibiotics
Drug Discovery
Pharmacology
Development of Potent and Selective PfCLK3 Inhibitors Based on GSK-TCMDC151 as a New Class of Antimalarials
